BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38834066)

  • 1. Conformational landscape of the type V-K CRISPR-associated transposon integration assembly.
    Tenjo-Castaño F; Sofos N; Stutzke LS; Temperini P; Fuglsang A; Pape T; Mesa P; Montoya G
    Mol Cell; 2024 Jun; 84(12):2353-2367.e5. PubMed ID: 38834066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of the holo CRISPR RNA-guided transposon integration complex.
    Park JU; Tsai AW; Rizo AN; Truong VH; Wellner TX; Schargel RD; Kellogg EH
    Nature; 2023 Jan; 613(7945):775-782. PubMed ID: 36442503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target site selection and remodelling by type V CRISPR-transposon systems.
    Querques I; Schmitz M; Oberli S; Chanez C; Jinek M
    Nature; 2021 Nov; 599(7885):497-502. PubMed ID: 34759315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic details of CRISPR-associated transposon recruitment and integration revealed by cryo-EM.
    Park JU; Tsai AW; Chen TH; Peters JE; Kellogg EH
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2202590119. PubMed ID: 35914146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic discovery of CRISPR-associated transposons.
    Rybarski JR; Hu K; Hill AM; Wilke CO; Finkelstein IJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary and mechanistic diversity of Type I-F CRISPR-associated transposons.
    Klompe SE; Jaber N; Beh LY; Mohabir JT; Bernheim A; Sternberg SH
    Mol Cell; 2022 Feb; 82(3):616-628.e5. PubMed ID: 35051352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of target DNA recognition by CRISPR-Cas12k for RNA-guided DNA transposition.
    Xiao R; Wang S; Han R; Li Z; Gabel C; Mukherjee IA; Chang L
    Mol Cell; 2021 Nov; 81(21):4457-4466.e5. PubMed ID: 34450043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual modes of CRISPR-associated transposon homing.
    Saito M; Ladha A; Strecker J; Faure G; Neumann E; Altae-Tran H; Macrae RK; Zhang F
    Cell; 2021 Apr; 184(9):2441-2453.e18. PubMed ID: 33770501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of target site selection by type V-K CRISPR-associated transposases.
    George JT; Acree C; Park JU; Kong M; Wiegand T; Pignot YL; Kellogg EH; Greene EC; Sternberg SH
    Science; 2023 Nov; 382(6672):eadj8543. PubMed ID: 37972161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the assembly of the type V CRISPR-associated transposon complex.
    Schmitz M; Querques I; Oberli S; Chanez C; Jinek M
    Cell; 2022 Dec; 185(26):4999-5010.e17. PubMed ID: 36435179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the miniature type V-F CRISPR-Cas effector enzyme.
    Takeda SN; Nakagawa R; Okazaki S; Hirano H; Kobayashi K; Kusakizako T; Nishizawa T; Yamashita K; Nishimasu H; Nureki O
    Mol Cell; 2021 Feb; 81(3):558-570.e3. PubMed ID: 33333018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-EM structure of a type I-F CRISPR RNA guided surveillance complex bound to transposition protein TniQ.
    Li Z; Zhang H; Xiao R; Chang L
    Cell Res; 2020 Feb; 30(2):179-181. PubMed ID: 31900425
    [No Abstract]   [Full Text] [Related]  

  • 13. Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration.
    Klompe SE; Vo PLH; Halpin-Healy TS; Sternberg SH
    Nature; 2019 Jul; 571(7764):219-225. PubMed ID: 31189177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism for Tn7-like transposon recruitment by a type I-B CRISPR effector.
    Wang S; Gabel C; Siddique R; Klose T; Chang L
    Cell; 2023 Sep; 186(19):4204-4215.e19. PubMed ID: 37557170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel molecular requirements for CRISPR RNA-guided transposition.
    Walker MWG; Klompe SE; Zhang DJ; Sternberg SH
    Nucleic Acids Res; 2023 May; 51(9):4519-4535. PubMed ID: 37078593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
    Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Associated Transposase for Targeted Mutagenesis in Diverse Proteobacteria.
    Trujillo Rodríguez L; Ellington AJ; Reisch CR; Chevrette MG
    ACS Synth Biol; 2023 Jul; 12(7):1989-2003. PubMed ID: 37368499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.
    Rollins MF; Chowdhury S; Carter J; Golden SM; Miettinen HM; Santiago-Frangos A; Faith D; Lawrence CM; Lander GC; Wiedenheft B
    Mol Cell; 2019 Apr; 74(1):132-142.e5. PubMed ID: 30872121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
    Liu L; Yin M; Wang M; Wang Y
    Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.